Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Biofrontera (BFRIW) Cost of Revenue (2020 - 2025)

Biofrontera has reported Cost of Revenue over the past 6 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $3.0 million for Q4 2025, down 42.91% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (down 41.07% YoY), and the annual figure for FY2025 was $11.0 million, down 41.08%.
  • Cost of Revenue for Q4 2025 was $3.0 million at Biofrontera, up from $2.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for BFRIW hit a ceiling of $17.5 million in Q4 2022 and a floor of -$1.4 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $2.7 million (2023), compared with a mean of $2.9 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 9554.7% in 2022 and later tumbled 107.76% in 2023.
  • Biofrontera's Cost of Revenue stood at $181000.0 in 2021, then skyrocketed by 9554.7% to $17.5 million in 2022, then tumbled by 107.76% to -$1.4 million in 2023, then soared by 488.72% to $5.3 million in 2024, then crashed by 42.91% to $3.0 million in 2025.
  • The last three reported values for Cost of Revenue were $3.0 million (Q4 2025), $2.0 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.